
Neoadjuvant immunotherapy and radiotherapy for muc...
Patients with mucosal melanoma are likely to have poor outcomes with current standard-of-care treatment options. The reasons are multifactorial but include difficulty obtai...
Learn about our #GetNaked Campaign View Campaign
Guest blog post by Ian Michael Crumm, Celebrity Esthetician, Podcast Host, Key Opinion Leader, Melanoma Advocate and 2025 #GetNaked Spokesperson: Some moments stick with yo...
Patients with mucosal melanoma are likely to have poor outcomes with current standard-of-care treatment options. The reasons are multifactorial but include difficulty obtai...
Description: Mucosal melanoma (MM) is a rare form of melanoma with poor survival outcomes. Data on treatment for MM is limited to results from studies on cutaneous melanoma...
Immunotherapy has fundamentally changed the way we treat melanoma patients. Checkpoint blockade specifically, which unleashes T cell killing of cancer cells, has extended p...
Mucosal melanoma presents a significant challenge for oncologists. Compared to cutaneous melanoma, mucosal melanoma has a far lower survival rate and is more difficult to t...
The Susan Fazio Melanoma Research Foundation Award
In memory of Susan Fazio and Lenore Goldberg
May 20, 2025